Adiuvo launched its operations in mid-2013. The company engages in the selection, development, financing and commercialization of innovative biomedical projects on international markets.
We focus on development and international commercialization of patented and clinically validated life-science projects, especially digital health and nutraceutical projects, including functional food. New development directions in the sector and in patients’ approach to their health, have led to new trends in products designed to help patients actively take part in monitoring and caring about their own health.
Generała Józefa Zajączka 11/14, 01-510 Warszawa – Poland
May 1, 2015Stock exchange(s)
Warsaw Stock Exchange
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.